Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial

@inproceedings{Jerzewski2013DoesHL,
  title={Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial},
  author={Katie Jerzewski and Marc A Ruel and Pierre Voisine and Michel R. Le May and Alexander Kulik},
  booktitle={Journal of cardiothoracic surgery},
  year={2013}
}
BACKGROUND Low levels of high-density lipoprotein (HDL) purportedly increase the risk after coronary bypass surgery. This may relate to the development of saphenous vein graft (SVG) disease early postoperatively, but this premise has never been evaluated in the context of a prospective trial. METHODS The CASCADE Trial was a multi-center study of 113 patients evaluating the use of postoperative clopidogrel. Patients received standard lipid management after surgery (96% statins). At 12 months… CONTINUE READING